Daily Stock Analysis, FMS, Fresenius Medical Care AG & Co KGaA, priceseries

Fresenius Medical Care AG & Co KGaA. Daily Stock Analysis
Stock Information
Open
37.65
Close
37.77
High
37.92
Low
37.61
Previous Close
37.41
Daily Price Gain
0.36
YTD High
42.04
YTD High Date
May 3, 2019
YTD Low
30.47
YTD Low Date
Jan 3, 2019
YTD Price Change
5.73
YTD Gain
17.90%
52 Week High
52.51
52 Week High Date
Aug 29, 2018
52 Week Low
30.47
52 Week Low Date
Jan 3, 2019
52 Week Price Change
-11.74
52 Week Gain
-23.71%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 5. 2017
49.26
Feb 1. 2018
54.43
39 Trading Days
10.49%
Link
LONG
Jan 15. 2019
33.66
Feb 11. 2019
36.30
18 Trading Days
7.84%
Link
Company Information
Stock Symbol
FMS
Exchange
NYSE
Company URL
http://www.freseniusmedicalcare.com
Company Phone
0114961726092525
CEO
Rice Powell
Headquarters
-
Business Address
ELSE-KRONER STRASSE 1, BAD HOMBURG, GERMANY D-61352
Sector
Equity
Industry Category
Health Services
Industry Group
Specialized Health Services
CIK
0001019600
About

Fresenius Medical Care AG & Co. KGaA provides products and services for patients with chronic kidney failure. Its products include dialysis machines, dialyzers, and related disposables. It also offers renal information technology solutions and provides services such as renal replacement therapy and therapeutic apheresis. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Description

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, and endovascular specialty, as well as hospitalist and intensivist, and medical cost management services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers laboratory services that include general testing, clinical anatomic pathology, and molecular testing. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2016, it operated 3,624 dialysis clinics in approximately 45 countries worldwide. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.